1. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation
   Renata M. Martinez et al, 2020, Molecules CrossRef
2. The anti-inflammatory effect of BML-111 on COPD may be mediated by regulating NLRP3 inflammasome activation and ROS production
   Yuan Cao et al, 2018, Prostaglandins & Other Lipid Mediators CrossRef
3. Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway
   Qiuping Wu et al, 2019, International Immunopharmacology CrossRef
4. Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
   Xia Kong et al, 2017, Experimental and Therapeutic Medicine CrossRef
5. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes
   Amanda Croasdell et al, 2016, The FASEB Journal CrossRef
6. BML-111 Reduces Neuroinflammation and Cognitive Impairment in Mice With Sepsis via the SIRT1/NF-κB Signaling Pathway
   Shangwen Pan et al, 2018, Frontiers in Cellular Neuroscience CrossRef
7. 15-epi-Lipoxin A4, Resolvin D2, and Resolvin D3 Induce NF-κB Regulators in Bacterial Pneumonia
   Ho Pan Sham et al, 2018, The Journal of Immunology CrossRef
8. LXA4 inhibits TGF-β1-induced airway smooth muscle cells proliferation and migration by suppressing the Smad/YAP pathway
   Yali Zhao et al, 2023, International Immunopharmacology CrossRef
9. Targeted inhibition of GATA-6 attenuates airway inflammation and remodeling by regulating caveolin-1 through TLR2/MyD88/NF-κB in murine model of asthma
   Ping Fang et al, 2016, Molecular Immunology CrossRef
10. The lipoxin A4 agonist BML-111 attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats
    Ghada S. El-Tanbouly et al, 2017, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
11. Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway
    Ting Zhang et al, 2020, Prostaglandins & Other Lipid Mediators CrossRef